Guardant Health, Inc. (GH) Management on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/05/22
Guardant Health to Report Second Quarter 2022 Financial Results on August 4, 2022Business Wire • 07/13/22
Guardant Health and Adicon announce strategic partnership to offer comprehensive genomic profiling tests to accelerate development of new cancer therapies in ChinaPRNewsWire • 07/06/22
First Guardant Health Liquid Biopsy Testing Service in Europe Now Operational at Vall d'Hebron Institute of OncologyBusiness Wire • 05/25/22
Guardant Health to Present New Data from its Broad Portfolio of Blood Tests at 2022 American Society of Clinical Oncology (ASCO) Annual MeetingBusiness Wire • 05/23/22
Guardant Health Presents New Data Showing Blood Test Accuracy in Detecting Colorectal Cancer in First-of-its Kind Prospective Study at Digestive Disease Week 2022Business Wire • 05/21/22
Guardant Health Announces Shield™ Blood Test Available in US to Detect Early Signs of Colorectal Cancer in Average-Risk AdultsBusiness Wire • 05/02/22
Earnings Preview: Guardant Health (GH) Q1 Earnings Expected to DeclineZacks Investment Research • 04/28/22
Guardant Health to Participate in the BofA Securities 2022 Healthcare ConferenceBusiness Wire • 04/28/22